A pilot study assessing the benefit of a combination of Dupilumab treatment with a short course of narrow-band ultraviolet B (NB-UVB) phototherapy in patients with severe Atopic Dermatitis
Latest Information Update: 08 Dec 2021
At a glance
- Drugs Dupilumab (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- 08 Dec 2021 New trial record